Equity and debt offerings as they're announced. https://www.quantisnow.com/news/offerings en-us Sun, 15 Nov 2026 06:22:28 GMT ROCHESTER, NEW YORK, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (NASDAQ:OPTX) ("Syntec Optics" or the "Company"), a provider of deep-tech products to industry pioneers connecting and protecting the world, today announced financial results for the third quarter ended September 30, 2026. Supporting mission-critical applications ranging from low-Earth-orbit satellites and bipartisan connected-battlefield defense platforms to life sciences, Syntec delivered an all-time high revenue of $8.5 million, up 23% year over year, and net income improved by $1.6 million to a positive net income of $0.2 million, compared with a $1.4 million net loss in the prior-year quarter. The quar https://www.quantisnow.com/insight/syntec-optics-nasdaq-optx-q3-hits-all-time-high-revenue-6791602 https://www.quantisnow.com/insight/syntec-optics-nasdaq-optx-q3-hits-all-time-high-revenue-6791602 Fri, 13 Nov 2026 22:57:57 GMT New York, NY, Nov. 13, 2026 (GLOBE NEWSWIRE) -- byNordic Acquisition Corporation ("BYNO" or the "Company"), a special purpose acquisition company, announced today that the Company has timely deposited into the Company’s trust account (the "Trust Account"), an aggregate of $8,850.20, in order to extend the period of time the Company has to complete a business combination for an additional one (1) month period, from November 12, 2026 to December 12, 2026 (the "Extension"). The Extension is the fourth of up to twelve (12) one-month extensions permitted under the August 7, 2026 amendment to the Company’s Amended and Restated Certificate of Incorporation that allows the Company’s board of dire https://www.quantisnow.com/insight/bynordic-acquisition-corporation-announces-extension-of-deadline-to-complete-business-6791259 https://www.quantisnow.com/insight/bynordic-acquisition-corporation-announces-extension-of-deadline-to-complete-business-6791259 Fri, 13 Nov 2026 21:57:30 GMT Board thanks Deborah C. Jackson for her service as Lead Director, and announces the retirement of Chair Emeritus Richard E. Holbrook and the resignation of Director Luis A. Borgen Eastern Bankshares, Inc. (the "Company") (NASDAQ:EBC), the holding company of Eastern Bank, today announced its Board of Directors (the "Board") has unanimously elected Peter K. Markell as Lead Independent Director, effective January 1, 2027. Mr. Markell will succeed Deborah C. Jackson, who will step down as Lead Director effective January 1, 2027, in anticipation of her planned retirement from the Board at year-end 2027. The Company also announced Director and Chair Emeritus Richard E. Holbrook will retire from https://www.quantisnow.com/insight/eastern-bankshares-inc-announces-board-leadership-transition-peter-k-markell-6790685 https://www.quantisnow.com/insight/eastern-bankshares-inc-announces-board-leadership-transition-peter-k-markell-6790685 Fri, 13 Nov 2026 21:15:00 GMT Reports Q3 2026 GAAP Net Loss of $14.0 Million and First Nine Months 2026 GAAP Net Loss of $35.0 MillionReports Q3 2026 Adjusted Net Loss of $10.2 Million and First Nine Months 2026 Adjusted Net Loss of $23.5 Million (Non-GAAP)Ended Quarter with $9.2 Million in Cash and Cash Equivalents; Raised Approximately $6.0 Million in Gross Proceeds During the Quarter in a Warrant Inducement TransactionIssued Purchase Orders for Bodies and Chassis for Initial Production Vehicles and Entered into a Strategic Partnership Agreement with Shanghai Launch Automotive TechnologyRaised Approximately $23.1 Million in Gross Proceeds in the First Nine Months of 2026 Through a Public Offering and Warrant Inducement https://www.quantisnow.com/insight/aptera-motors-reports-third-quarter-and-first-nine-months-2026-6790442 https://www.quantisnow.com/insight/aptera-motors-reports-third-quarter-and-first-nine-months-2026-6790442 Fri, 13 Nov 2026 21:05:00 GMT Conference Call and Webcast Today, November 13, 2026 at 4:30 p.m. ET (800) 715-9871 or +1 (646) 307-1963, conference ID 1613596 or www.bbgi.com Replay information provided below NAPLES, Fla., Nov. 13, 2026 /PRNewswire/ -- Beasley Broadcast Group, Inc. (NASDAQ:BBGI) ("Beasley" or the "Company"), a multi-platform media company, today announced operating results for the three-month period ended September 30, 2026. For further information, the Company has posted a presentation to its website regarding the first quarter highlights and accomplishments that management will review on today's conference call.  Third Quarter Financial H https://www.quantisnow.com/insight/beasley-broadcast-group-reports-third-quarter-revenue-of-428-million-6790324 https://www.quantisnow.com/insight/beasley-broadcast-group-reports-third-quarter-revenue-of-428-million-6790324 Fri, 13 Nov 2026 21:00:00 GMT Developed by Eve and utilized by Revo, the Vector system contributed to managing ground operations and helicopter flight slots over the weekend, supporting logistics at the circuit's main helipad, with a peak of more than 100 flights in a single dayMELBOURNE, Fla., Nov. 13, 2026 /PRNewswire/ -- Eve Air Mobility ("Eve") (NYSE:EVEX, EVEXW, B3: EVEB31)) contributed its ground operations and helicopter flight slot management system during the largest international motorsport event, held this weekend at the Interlagos Circuit in São Paulo. Revo — a pioneer in providing a door-to-door urban air mobility journey in Brazil — is a customer of Eve, an Embraer Group company. https://www.quantisnow.com/insight/eve-air-mobility-technology-supports-helicopter-operations-during-one-of-6790047 https://www.quantisnow.com/insight/eve-air-mobility-technology-supports-helicopter-operations-during-one-of-6790047 Fri, 13 Nov 2026 18:29:00 GMT NEWPORT BEACH, California, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Blue Acquisition Corp. ("Blue," or the "Company") (NASDAQ:BACC) announced today that it has postponed until further announcement the date of the extraordinary general meeting of the Company’s shareholders (the "Meeting") to approve its proposed business combination (the "Business Combination") with Blockfusion USA, Inc. ("Blockfusion") that had been scheduled for 10:00 a.m. Eastern Time on November 17, 2026. At the Meeting, the shareholders will vote on the proposals set forth in Blue’s proxy statement/prospectus dated October 22, 2026 and filed with the Securities and Exchange Commission (the "SEC") to approve the Business Comb https://www.quantisnow.com/insight/blue-acquisition-corp-announces-postponement-of-the-extraordinary-general-meeting-6789825 https://www.quantisnow.com/insight/blue-acquisition-corp-announces-postponement-of-the-extraordinary-general-meeting-6789825 Fri, 13 Nov 2026 16:09:07 GMT BOCA RATON, FL, Nov. 13, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (NASDAQ:DFDV) (the "Company"), the first public company with a treasury strategy built to accumulate and compound Solana ("SOL"), today announced that its Variable Rate Series C Perpetual Preferred Stock (NASDAQ:CHAD) has completed 30 consecutive business-day dividend payments, from its first regular dividend payment on October 1, 2026 through [TK: November 13, 2026]. CHAD, a daily dividend preferred stock and SOL-powered digital credit instrument, currently pays a variable annual dividend rate of 14.00%, or $1.40 per share per year on its $10.00 stated amount ($0.00614 per share each business day in the November 202 https://www.quantisnow.com/insight/defi-development-corps-chad-preferred-stock-completes-30-consecutive-daily-6789613 https://www.quantisnow.com/insight/defi-development-corps-chad-preferred-stock-completes-30-consecutive-daily-6789613 Fri, 13 Nov 2026 14:00:00 GMT MONROE TOWNSHIP, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. ("OPT" or the "Company") (NYSE:OPTT), a leader in intelligent maritime solutions and services, today announced the pricing of its previously announced public offering of 6,000,000 shares of common stock together with common warrants to purchase up to 6,000,000 shares of common stock, on a "best-efforts" basis (the "Offering"). The warrants will have an exercise price of $0.50 per share and will expire 5 years from the date of issuance. The common stock is listed on the NYSE American under the symbol "OPTT". D. Boral Capital LLC is acting as the exclusive placement agent for the Offering. The closing o https://www.quantisnow.com/insight/ocean-power-technologies-announces-pricing-of-30-million-public-offering-6789506 https://www.quantisnow.com/insight/ocean-power-technologies-announces-pricing-of-30-million-public-offering-6789506 Fri, 13 Nov 2026 13:27:05 GMT MIAMI, Nov. 13, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the pricing of its previously announced underwritten public offering of (i) 7,342,308 shares of its common stock, (ii) in lieu of common stock to certain investors, pre-funded warrants to purchase 50,350,000 shares of its common stock, and (iii) accompanying common warrants to purchase 43,269,231 shares of its common stock (or pre-funded warrants in lieu thereof). All securities in the offering are being offered by InspireMD. In addition, the Company granted the underwriters a 30-day option https://www.quantisnow.com/insight/inspiremd-announces-pricing-of-375-million-public-offering-6789483 https://www.quantisnow.com/insight/inspiremd-announces-pricing-of-375-million-public-offering-6789483 Fri, 13 Nov 2026 13:12:12 GMT HONG KONG, Nov. 13, 2026 (GLOBE NEWSWIRE) -- 3 E Network Technology Group Limited (NASDAQ:MASK) (the "Company" or "3e Network"), a business-to-business ("B2B") information technology ("IT") business solutions provider, today announced the closing of its previously announced private placement of Class A ordinary shares, par value US$0.01 per share, at a purchase price of approximately US$3.634 per share (the "Private Placement"). Under the subscription agreement dated October 23, 2026 (the "Subscription Agreement"), entered into by the Company, 3E NETWORK TECHNOLOGY PTE. LTD., an entity controlled by the Company’s Chief Executive Officer, Dr. Tingjun Yang (the "Yang Investor"), and six ind https://www.quantisnow.com/insight/3-e-network-technology-group-limited-announces-closing-of-us50-6789417 https://www.quantisnow.com/insight/3-e-network-technology-group-limited-announces-closing-of-us50-6789417 Fri, 13 Nov 2026 12:50:00 GMT EL MONTE, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (NASDAQ:GCT) ("GigaCloud" or the "Company"), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced the appointment of Sarah Anzalone as Head of Brand Center, effective November 30, 2026. Ms. Anzalone joined GigaCloud in September 2026 and has since worked alongside Marshall Bernes, whom she will succeed upon his planned retirement from the role on the same date. Mr. Bernes’ retirement was previously announced by the Company in April. Over the past three years, Mr. Bernes has played a key role in developing the Company’s Brand Center, drawing on his extensi https://www.quantisnow.com/insight/gigacloud-technology-inc-names-sarah-anzalone-head-of-brand-center-6789291 https://www.quantisnow.com/insight/gigacloud-technology-inc-names-sarah-anzalone-head-of-brand-center-6789291 Fri, 13 Nov 2026 12:00:00 GMT 12 of 13 Multifamily Properties Now Sold; Proceeds Used to Reduce Debt Sale of Final Multifamily Property, Premier Apartments, Expected to Close in Q2 2027 VIRGINIA BEACH, Va., Nov. 13, 2026 (GLOBE NEWSWIRE) -- AH Realty Trust (NYSE:AHRT) ("AHRT" or the "Company") today announced it has completed the sale of Greenside Apartments, a 225-unit multifamily property in Charlotte, North Carolina, to affiliates of Harbor Group International, LLC ("HGI") at the full contract price, with no subsequent adjustment. The Company used the proceeds to further reduce debt. This closing marks the sale of the 12th of 13 multifamily properties AH Realty Trust identified for sale as part of its strategic t https://www.quantisnow.com/insight/ah-realty-trust-completes-sale-of-greenside-apartments-6789250 https://www.quantisnow.com/insight/ah-realty-trust-completes-sale-of-greenside-apartments-6789250 Fri, 13 Nov 2026 11:16:00 GMT ADVERTISEMENT This advertisement constitutes an advertisement within the meaning of the Prospectus Regulation and marketing communication within the meaning of MiFID II and is prepared by and in the sole responsibility of Interactive Brokers Ireland Limited, North Dock One, 91/92 North Wall Quay, Dublin 1, D01 H7V7, Ireland, a firm authorized and regulated by the Central Bank of Ireland. Eligible clients of Interactive Brokers Ireland Limited can participate in the offering. Interactive Brokers Ireland Limited, part of Interactive Brokers Group (NASDAQ:IBKR), an automated global broker, today announced that eligible clients can participate in the initial public offering (the "Offering") https://www.quantisnow.com/insight/interactive-brokers-offers-eligible-clients-access-to-the-anthropic-pbc-6789153 https://www.quantisnow.com/insight/interactive-brokers-offers-eligible-clients-access-to-the-anthropic-pbc-6789153 Fri, 13 Nov 2026 10:00:00 GMT FRISCO, Texas and BURLINGTON, Mass., Nov. 12, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ:KDP) ("KDP" or the "Company") today announced the pricing of its previously announced underwritten public offering of 57,971,015 shares of its common stock, par value $0.01 per share (the "Offering"), at a price to the public of $34.50 per share. KDP's common stock is listed on the Nasdaq Global Select Market under the symbol "KDP."KDP has granted the underwriters of the Offering a 30-day option to purchase up to an additional 8,695,652 shares of common stock, at the same price per share as the other shares of common stock purchased by the underwriters in the Offering. The Offering is expected to https://www.quantisnow.com/insight/keurig-dr-pepper-announces-pricing-of-public-offering-of-common-6789128 https://www.quantisnow.com/insight/keurig-dr-pepper-announces-pricing-of-public-offering-of-common-6789128 Fri, 13 Nov 2026 02:21:00 GMT Vir Biotechnology, Inc. (NASDAQ:VIR), a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer, today announced the pricing of its underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $10.00 per share. The gross proceeds to Vir Biotechnology from the offering are expected to be $150 million, before deducting underwriting discounts and commissions and offering expenses. In addition, Vir Biotechnology has granted the underwriters a 30-day option to purchase up to an additional 2,250,000 shares of its common stock at the publ https://www.quantisnow.com/insight/vir-biotechnology-announces-pricing-of-public-offering-of-common-stock-6789068 https://www.quantisnow.com/insight/vir-biotechnology-announces-pricing-of-public-offering-of-common-stock-6789068 Fri, 13 Nov 2026 00:38:00 GMT Strong Cash Conversion and Continued Earnings Growth Full-Year 2026 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and nine-month period, which ended September 30, 2026 (third quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards ("IFRS"). These materials are not an offer for sale of securities in the United States, nor a solicitation of votes or proxies. The securities have not been registered under the U. https://www.quantisnow.com/insight/afya-limited-announces-third-quarter-and-nine-months-2026-financial-6789015 https://www.quantisnow.com/insight/afya-limited-announces-third-quarter-and-nine-months-2026-financial-6789015 Thu, 12 Nov 2026 23:38:00 GMT JILIN, China, Nov. 12, 2026 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in China, today announced its unaudited financial results for the six months ended June 30, 2026. Mr. Songlin Song, co-chief executive officer of Zhengye, remarked, "During the first half of fiscal year 2026, we continued to enhance profitability through disciplined cost management and operational efficiency. Despite the decline in net revenue and gross profit, we are encouraged by the improvement in our gross pr https://www.quantisnow.com/insight/zhengye-biotechnology-holding-limited-announces-financial-results-for-the-first-6788361 https://www.quantisnow.com/insight/zhengye-biotechnology-holding-limited-announces-financial-results-for-the-first-6788361 Thu, 12 Nov 2026 21:30:00 GMT Thirteen Recent Acquisitions Totaling $45.5 Million of Core Appalachia and Haynesville Mineral and Royalty Interests Record Production of 71.3 MMcfe/d for the Third Quarter 2026, Up 10% Year-Over-Year and 2% Compared to the Second Quarter 2026 Declared Dividend of $0.50 Per Share ($2.00 Annualized) WhiteHawk Minerals Corp. (NYSE:WHK) ("WhiteHawk" or the "Company") today announced the signing of $45.5 million of natural gas mineral and royalty acquisitions since August 13, 2026, as well as operating and financial results for the third quarter ended September 30, 2026. WhiteHawk will host a conference call and webcast to discuss its results for the third quarter of 2026 on November 13, https://www.quantisnow.com/insight/whitehawk-minerals-corp-announces-455-million-of-acquisitions-third-quarter-6788353 https://www.quantisnow.com/insight/whitehawk-minerals-corp-announces-455-million-of-acquisitions-third-quarter-6788353 Thu, 12 Nov 2026 21:30:00 GMT WILMINGTON, N.C., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (NYSE:LOB) ("Live Oak" or the "Company") announced the closing of its previously announced underwritten offering of 4,000,000 depositary shares, each representing a 1/40th interest in a share of its 8.750% Fixed Rate Series B Non-Cumulative Perpetual Preferred Stock (the "Series B Preferred Stock"), with a liquidation preference of $25 per depositary share. As a result of the public offering, Live Oak received proceeds of approximately $96,250,000, net of estimated expenses and underwriting discounts and commissions. Morgan Stanley & Co. LLC; Keefe, Bruyette & Woods, A Stifel Company; RBC Capital Markets, LLC; a https://www.quantisnow.com/insight/live-oak-bancshares-inc-closes-depositary-share-offering-6788340 https://www.quantisnow.com/insight/live-oak-bancshares-inc-closes-depositary-share-offering-6788340 Thu, 12 Nov 2026 21:30:00 GMT CAMBRIDGE, Mass., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (NASDAQ:PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of its underwritten public offering of 41,071,428 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 5,357,142 additional shares of its common stock, at a public offering price of $3.50 per share. All of the shares of common stock in the offering were sold by Prime Medicine. The gross proceeds to Prime Medicine from the offering, before deducting underwriting discounts and commissions and offering expenses, were a https://www.quantisnow.com/insight/prime-medicine-announces-closing-of-public-offering-and-full-exercise-6788087 https://www.quantisnow.com/insight/prime-medicine-announces-closing-of-public-offering-and-full-exercise-6788087 Thu, 12 Nov 2026 21:15:48 GMT MIAMI, Nov. 12, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it has commenced a proposed public offering of (i) shares of its common stock, (ii) in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock, and (iii) accompanying common warrants to purchase shares of its common stock or pre-funded warrants in lieu thereof to purchase shares of its common stock. All securities in the proposed offering are being offered by InspireMD. In addition, the Company intends to grant the underwriters a 30-day opti https://www.quantisnow.com/insight/inspiremd-announces-proposed-public-offering-6788040 https://www.quantisnow.com/insight/inspiremd-announces-proposed-public-offering-6788040 Thu, 12 Nov 2026 21:15:00 GMT IntentKey’s Privacy-By-Design Value Proposition Resonates as Sales Pipeline Builds Legacy Search Revenue Stabilizes Management to host conference call at 4:15 PM ET, Thursday, November 12, 2026 LITTLE ROCK, Ark., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE:INUV), a provider of artificial intelligence-driven solutions for modeling media audiences, today announced financial results for the third quarter and nine months ended September 30, 2026, and provided a business update. Recent Business Highlights Audience Modeling Revenue Down While Pipeline Builds: Third quarter Audience Modeling revenue was 24% lower year-over-year while our sales pipeline expanded across automotive, tr https://www.quantisnow.com/insight/inuvo-third-quarter-2026-results-reflect-inflection-point-as-intentkey-6787988 https://www.quantisnow.com/insight/inuvo-third-quarter-2026-results-reflect-inflection-point-as-intentkey-6787988 Thu, 12 Nov 2026 21:12:31 GMT Vir Biotechnology, Inc. (NASDAQ:VIR), a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer, today announced that it intends to offer shares of its common stock in an underwritten public offering. In addition, Vir Biotechnology intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of its common stock to be sold in the offering at the public offering price, less underwriting discounts and commissions. All of the shares in the proposed offering will be offered by Vir Biotechnology. The proposed offering is subje https://www.quantisnow.com/insight/vir-biotechnology-announces-proposed-public-offering-6787820 https://www.quantisnow.com/insight/vir-biotechnology-announces-proposed-public-offering-6787820 Thu, 12 Nov 2026 21:08:00 GMT Record GAAP revenue of $210.8 millionRecord Core revenue of $230.9 millionGAAP cloud revenue grew 265% from a year agoCore cloud revenue $144.9 million, up 272% from a year agoCommercial wins with two new hyperscalers700 megawatts of data center capacity now under contractFirst to deliver production scale heterogeneous disaggregated inference offering SUNNYVALE, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Cerebras Systems (NASDAQ:CBRS), maker of the world’s fastest AI infrastructure, today announced financial results for the third quarter ended September 30, 2026. "Cerebras’ technology remains the undisputed champion of speed," said Andrew Feldman, co-founder and CEO of Cerebras. "We’re gi https://www.quantisnow.com/insight/cerebras-systems-delivers-record-revenue-in-third-quarter-2026-raises-6787687 https://www.quantisnow.com/insight/cerebras-systems-delivers-record-revenue-in-third-quarter-2026-raises-6787687 Thu, 12 Nov 2026 21:05:00 GMT Product revenue grew 24% to $5.7 million, driven by strong software licensing performance; gross margin reached 90% for the second consecutive quarter Measurable results validate ROC’s core growth drivers; ROC ABIS grew 654% YoY to $2.2M and ROC SDK grew 52% YoY to $2.6M Secured transformational federal beachhead contracts for ROC ABIS and ROC Evidence, including a $64.3 million Department of Justice digital evidence contract award, the largest in Company history DENVER, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Rank One Computing Corporation d/b/a ROC (NASDAQ:ROC) ("ROC" or the "Company"), a U.S. leader in Vision AI, building unified biometric, video analytics, and digital evidence solutions, https://www.quantisnow.com/insight/roc-delivers-record-quarterly-revenue-of-80-million-in-the-6787677 https://www.quantisnow.com/insight/roc-delivers-record-quarterly-revenue-of-80-million-in-the-6787677 Thu, 12 Nov 2026 21:05:00 GMT Third Quarter 2026 Business Highlights Revenue grew 65.9% year over year to $202.2 million.Bookings of $768.9 million, an increase of 364% year over year.Backlog of $1.7 billion, an increase of 329% and 51.0% over prior year and prior quarter, respectively.Book-to-bill ratio of 3.8x.Net income was $3.2 million, a decline of $10.5 million; net income margin was 1.6%.Adjusted net income* was $20.9 million, a decline of 7.0%.Adjusted EBITDA* increased by $8.9 million to $37.7 million; Adjusted EBITDA margin* was 18.7%.Operating cash flow increased to $62.5 million from an outflow of $0.6 million in the prior year.Subsequent to quarter end, the Company entered into a new $650 million senior sec https://www.quantisnow.com/insight/accelevation-holdings-corp-reports-strong-third-quarter-2026-with-revenue-6787658 https://www.quantisnow.com/insight/accelevation-holdings-corp-reports-strong-third-quarter-2026-with-revenue-6787658 Thu, 12 Nov 2026 21:05:00 GMT Record Collections Grow 35% to $319.2 Million and Deployments grow 111% to $318.0 MillionRecord Estimated Remaining Collections ("ERC") up 23% to $3.6 BillionPre-tax Income of $58.9 Million with Net Income of $46.9 Million and EPS of $0.76Adjusted Pre-tax Income of $63.3 Million with Adjusted Net Income of $51.3 Million and Adjusted EPS of $0.83Board of Directors Declares Quarterly Cash Dividend of $0.24 per Share MINNEAPOLIS, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Jefferson Capital, Inc. ("Jefferson Capital, the "Company"), a leading analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts, today announced its third quarter 2026 financial results. Thi https://www.quantisnow.com/insight/jefferson-capital-reports-third-quarter-2026-results-6787644 https://www.quantisnow.com/insight/jefferson-capital-reports-third-quarter-2026-results-6787644 Thu, 12 Nov 2026 21:05:00 GMT NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (NASDAQ:TMC) ("TMC" or "the Company"), a leading developer of the world’s largest resource of critical metals essential to energy, defense, manufacturing and infrastructure, today provided a corporate update and third quarter financial results for the period ended September 30, 2026. Q3 2026 Financial Highlights Liquidity of approximately $123 million available from our cash on hand and our credit facilities as of September 30, 2026$19.4 million cash used in operations for the quarter ended September 30, 2026Net loss of $28.4 million and net loss per share of 6 cents for the quarter ended September 30, 2026 TM https://www.quantisnow.com/insight/tmc-provides-third-quarter-2026-corporate-update-6787530 https://www.quantisnow.com/insight/tmc-provides-third-quarter-2026-corporate-update-6787530 Thu, 12 Nov 2026 21:02:00 GMT Management to host conference call and webcast today at 4:30 p.m. ETLEXINGTON, Mass., Nov. 12, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its financial and operating results for the third quarter ended September 30, 2026. "We are encouraged by our progress in both the TakeAim CLL study and the TakeAim Lymphoma study," said James Dentzer, Chief Executive Officer of Curis. "The excitement among clinicians and patients reflects the clear unmet need in both CLL and PCNSL, whe https://www.quantisnow.com/insight/curis-provides-third-quarter-2026-business-update-6787496 https://www.quantisnow.com/insight/curis-provides-third-quarter-2026-business-update-6787496 Thu, 12 Nov 2026 21:01:00 GMT ERAS-0015 granted FDA Fast Track Designation for metastatic pancreatic adenocarcinoma; advancing toward three potentially registration-enabling trials in pancreatic and lung cancers Updated ERAS-0015 monotherapy and nonclinical ERAS-0015/ERAS-4001 combination data to be presented at ENA; expect preliminary ERAS-4001 data in H2 2026 and ERAS-0015 data in H1 2027 Cash, cash equivalents, and marketable securities of $948 million as of September 30, 2026 SAN DIEGO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven canc https://www.quantisnow.com/insight/erasca-reports-third-quarter-2026-business-updates-and-financial-results-6787485 https://www.quantisnow.com/insight/erasca-reports-third-quarter-2026-business-updates-and-financial-results-6787485 Thu, 12 Nov 2026 21:01:00 GMT CAMBRIDGE, Mass., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Akamai Technologies, Inc. (NASDAQ:AKAM) ("Akamai") today announced that it has closed its previously announced private offering of $1.25 billion in aggregate principal amount of 1.00% convertible senior notes due 2028 (the "2028 Notes") and $1.25 billion in aggregate principal amount of 1.00% convertible senior notes due 2031 (the "2031 Notes" and, together with the 2028 Notes, the "notes") to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The aggregate principal amount of each series of notes includes $150.0 million issued pursu https://www.quantisnow.com/insight/akamai-announces-closing-of-25-billion-offering-of-convertible-senior-6787404 https://www.quantisnow.com/insight/akamai-announces-closing-of-25-billion-offering-of-convertible-senior-6787404 Thu, 12 Nov 2026 20:07:50 GMT Initiated the Company’s third Phase 1b clinical trial, BActinium-2, broadening the evaluation of AKY-2519 to lung cancer and other B7-H3 expressing tumorsStarted first backfill cohorts in the ongoing Phase 1b NECTINIUM-2 clinical trial of AKY-1189 and Phase 1b BActinium-1 clinical trial of AKY-2519On track to present preliminary data for AKY-1189 in first quarter of 2027 and AKY-2519 in 2027 BOSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) ("Aktis" or the "Company"), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, today reported financial results for the third quarter end https://www.quantisnow.com/insight/aktis-oncology-reports-third-quarter-financial-results-and-highlights-clinical-trial-6786400 https://www.quantisnow.com/insight/aktis-oncology-reports-third-quarter-financial-results-and-highlights-clinical-trial-6786400 Thu, 12 Nov 2026 13:00:00 GMT The AI Brain for Batteries™ platform goes trackside as ELECTRA AI races as the Official Battery Intelligence Partner, with its branding on the team's RaceBird ELECTRA AI ("ELECTRA"), the AI Brain for Batteries™ platform, and Iron Horse Acquisition II Corp. (NASDAQ:IRHO) ("Iron Horse") today announced that ELECTRA AI races as the Official Battery Intelligence Partner of Westbrook Racing by Visit Angola at the E1 Miami GP 2026, November 11–14. ELECTRA AI branding debuts on the team's RaceBird, bringing the company's battery intelligence from the data room to the water. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112605001/ https://www.quantisnow.com/insight/electra-ai-and-iron-horse-acquisition-ii-corp-take-to-6786397 https://www.quantisnow.com/insight/electra-ai-and-iron-horse-acquisition-ii-corp-take-to-6786397 Thu, 12 Nov 2026 13:00:00 GMT FRISCO, Texas and BURLINGTON, Mass., Nov. 12, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ:KDP) ("KDP" or the "Company") today announced that it has commenced an underwritten public offering of $2.0 billion of shares of its common stock, par value $0.01 per share (the "Offering"). KDP's common stock is listed on the Nasdaq Global Select Market under the symbol "KDP."KDP intends to grant the underwriters of the Offering a 30-day option to purchase up to an additional $300 million of shares of common stock, at the same price per share as the other shares of common stock purchased by the underwriters in the Offering. The Offering is subject to market and other customary conditions.Consist https://www.quantisnow.com/insight/keurig-dr-pepper-announces-proposed-public-offering-of-common-stock-6786326 https://www.quantisnow.com/insight/keurig-dr-pepper-announces-proposed-public-offering-of-common-stock-6786326 Thu, 12 Nov 2026 12:41:00 GMT SHOEMAKERSVILLE, Pa., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. ("Hydrofarm" or the "Company") (NASDAQ:HYFM) today announced that it has received confirmation from The Nasdaq Stock Market LLC ("Nasdaq") by letter dated November 9, 2026, that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(1), the $2.5 million minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market (the "Equity Rule"). "We received notice from Nasdaq that we are in compliance on our stockholders’ equity, another milestone in our financial restructuring," said Bill Toler, Chairman and Chief Executive Officer. "With this confirmation, our organiz https://www.quantisnow.com/insight/nasdaq-confirms-hydrofarms-compliance-with-stockholders-equity-requirement-6786157 https://www.quantisnow.com/insight/nasdaq-confirms-hydrofarms-compliance-with-stockholders-equity-requirement-6786157 Thu, 12 Nov 2026 12:15:00 GMT ATLANTA, Nov. 12, 2026 /PRNewswire/ -- Southern Company (NYSE:SO) today announced it plans to sell 35 million equity units in a public offering. Each equity unit will be issued in a stated amount of $50 ($1.75 billion aggregate stated amount) and will consist of a contract to purchase Southern Company common stock in the future and two 1/40 undivided beneficial ownership interests in remarketable senior notes each having a principal amount of $1,000. Southern Company expects to grant to the underwriters an option to purchase an additional 5 million equity units ($250 million aggregate stated amount) solely for the purpose of covering over-allotments. https://www.quantisnow.com/insight/southern-company-announces-equity-units-offering-6785911 https://www.quantisnow.com/insight/southern-company-announces-equity-units-offering-6785911 Thu, 12 Nov 2026 11:39:00 GMT Total Contract Backlog More Than Doubles to $577.2 Million and Funded Backlog Nearly Doubles to $119.6 Million; Company Completes First Commercial Reactor Core Delivery Total Contract Backlog* of $577.2 million at September 30, 2026, up from $241.5 million at June 30, 2026, with Funded Backlog nearly doubling to $119.6 million from $61.9 million; Total Contract Backlog and Qualified Pipeline together of approximately $1.4 billion In August 2026, executed a fuel supply agreement with Antares Nuclear, Inc. ("Antares") for a firm commitment of one metric ton of uranium contained in HALEU TRISO fuel (MTU), plus a customer option for up to seven additional MTU Completed delivery of th https://www.quantisnow.com/insight/standard-nuclear-reports-third-quarter-and-year-to-date-2026-results-6785605 https://www.quantisnow.com/insight/standard-nuclear-reports-third-quarter-and-year-to-date-2026-results-6785605 Thu, 12 Nov 2026 11:00:00 GMT SHENZHEN, China, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Xunlei Limited ("Xunlei" or the "Company") (NASDAQ:XNET), a leading technology company providing distributed cloud services in China, today announced its unaudited financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Financial Highlights (results presented herein exclude Shenzhen Onething, discontinued operations, unless specified otherwise1) Total revenues were US$101.3 million, representing an increase of 12.9% year-over-year. Subscription revenues were US$44.1 million, representing an increase of 8.5% year-over-year. Live-streaming and other services revenues were US$57.2 million, representing an incr https://www.quantisnow.com/insight/xunlei-announces-unaudited-financial-results-for-the-third-quarter-ended-6785576 https://www.quantisnow.com/insight/xunlei-announces-unaudited-financial-results-for-the-third-quarter-ended-6785576 Thu, 12 Nov 2026 10:00:00 GMT CareTrust REIT, Inc. (NYSE:CTRE) ("CareTrust REIT" or the "Company") announced the pricing of an underwritten public offering of an aggregate of 17,000,000 shares of its common stock sold on a forward basis in connection with the forward sale agreements described below, for gross proceeds of approximately $637.5 million. The underwriters may also purchase up to an additional 2,550,000 shares of the Company’s common stock within 30 days from the date of the prospectus supplement relating to the offering. The offering is expected to close on November 13, 2026 subject to customary closing conditions. BofA Securities, Morgan Stanley, J.P. Morgan and Wells Fargo Securities acted as book-runnin https://www.quantisnow.com/insight/caretrust-reit-inc-announces-pricing-of-public-offering-of-common-6785555 https://www.quantisnow.com/insight/caretrust-reit-inc-announces-pricing-of-public-offering-of-common-6785555 Thu, 12 Nov 2026 05:30:00 GMT PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company pioneering oligonucleotide therapies with the potential to transform the treatment of rare genetic diseases, today announced the pricing of a public offering of 25,000,000 shares of its common stock at a price to the public of $5.00 per share. The aggregate gross proceeds to PepGen from this offering are expected to be $125 million, before deducting underwriting discounts and commissions and offering expenses payable by PepGen. In addition, PepGen has granted the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of common stock at the public offering price, less the underwriting discounts and commi https://www.quantisnow.com/insight/pepgen-announces-pricing-of-125-million-public-offering-6785552 https://www.quantisnow.com/insight/pepgen-announces-pricing-of-125-million-public-offering-6785552 Thu, 12 Nov 2026 03:22:00 GMT New York, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the "Offering") of $3.5 million for its client Lichen International Limited (NASDAQ:LICN) (the "Company"), a dedicated financial and taxation service provider in China. Under the terms of the securities purchase agreement, the Company has agreed to sell to certain institutional investors an aggregate of 17,500,000 units (each, a "Unit"), consisting of one Class A Ordinary Share of the Company (or one pre-funded warrant in lieu thereof) https://www.quantisnow.com/insight/univest-securities-llc-announces-closing-of-35-million-registered-direct-6785534 https://www.quantisnow.com/insight/univest-securities-llc-announces-closing-of-35-million-registered-direct-6785534 Wed, 11 Nov 2026 22:46:18 GMT AEVEX Corp. (NYSE:AVEX) ("AEVEX" or the Company) announced results today for the three months ended September 30, 2026 ("Third Quarter 2026"). Total revenue of $189.7 million, up 56.5% from $121.2 million in Q3 2025 Net loss of $16.8 million compared to net income of $9.9 million in Q3 2025 Adjusted EBITDA* of $30.8 million compared to Adjusted EBITDA* of $17.8 million in Q3 2025 Completed the acquisition of BlackSea Technologies on September 8, 2026, establishing Maritime Systems as AEVEX’s third reportable segment Raised Outlook for Full Year 2026 Total revenue of $820.0 million to $840.0 million, compared to our prior range of $700.0 million to $720.0 million Adjuste https://www.quantisnow.com/insight/aevex-corp-announces-financial-results-for-third-quarter-2026-6785514 https://www.quantisnow.com/insight/aevex-corp-announces-financial-results-for-third-quarter-2026-6785514 Wed, 11 Nov 2026 21:40:00 GMT CareTrust REIT, Inc. (NYSE:CTRE) ("CareTrust REIT" or the "Company") announced that it has commenced, subject to market and other conditions, an underwritten public offering of an aggregate of 17,000,000 shares of its common stock in connection with the forward sale agreements described below.BofA Securities, Morgan Stanley, J.P. Morgan and Wells Fargo Securities are acting as the book-running managers for the offering.In connection with the offering of shares of its common stock, the Company expects to enter into separate forward sale agreements with each of Bank of America, N.A. and Morgan Stanley (or their respective affiliates), each referred to in such capacity as a forward purchaser. T https://www.quantisnow.com/insight/caretrust-reit-inc-announces-launch-of-public-offering-of-common-6785513 https://www.quantisnow.com/insight/caretrust-reit-inc-announces-launch-of-public-offering-of-common-6785513 Wed, 11 Nov 2026 21:37:00 GMT AUBURN HILLS, Mich., Nov. 11, 2026 /PRNewswire/ -- Custom Jeep® Wrangler Commando 392 to be auctioned exclusively to the public, with proceeds benefiting the USOFinal Jeep Wrangler Commando is the only public offering from a limited 250-unit program; 249 were reserved for active-duty military personnel and veteransOnline auto auction opens Nov. 11 and closes Nov. 22 on Bring a TrailerThe Jeep® brand, FOX Factory Vehicles and the USO announce the auction of a customized Jeep Wrangler Commando 392. The exclusive Jeep Wrangler Commando will be auctioned on Bring a Trailer from Nov. 11-22, with 100% of the proceeds benefiting the U https://www.quantisnow.com/insight/jeep-brand-fox-factory-vehicles-and-uso-partner-to-auction-6785390 https://www.quantisnow.com/insight/jeep-brand-fox-factory-vehicles-and-uso-partner-to-auction-6785390 Wed, 11 Nov 2026 17:00:00 GMT OSAKA, Japan, Nov. 11, 2026 (GLOBE NEWSWIRE) -- TryHard Holdings Limited ("TryHard" or the "Company") (NASDAQ:THH), a lifestyle entertainment platform in Japan, today announced that its wholly owned subsidiary, TryHard Japan Co., Ltd. ("TryHard Japan"), successfully operated a drone light show reportedly the largest in Japan, featuring 4,050 drones at the 2026 Saga International Balloon Fiesta on November 3, 2026, along the banks of the Kase River in Saga City, Japan. According to the event organizer, the performance attracted approximately 50,000 spectators, and featured synchronized drone formations accompanied by a live violin performance. The drone show was operated by TryHard Japan, https://www.quantisnow.com/insight/tryhard-dazzles-50000-spectators-with-4050-drone-light-show-at-saga-6785131 https://www.quantisnow.com/insight/tryhard-dazzles-50000-spectators-with-4050-drone-light-show-at-saga-6785131 Wed, 11 Nov 2026 12:00:00 GMT Greenwich, CT, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Southport Acquisition Corp. II (NYSE:PORT) (the "Company") announced today that, commencing November 16, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. The Class A ordinary shares and warrants that are separated will trade on the New York Stock Exchange under the symbols "PORT" and "PORT WS," respectively. Those units not separated will continue to trade on the New York Stock Exchange under the symbol "PORT U." This press release shall not constitute an offer to sell or the solicitation of an offer to buy the sec https://www.quantisnow.com/insight/southport-acquisition-corp-ii-announces-the-separate-trading-of-its-6785084 https://www.quantisnow.com/insight/southport-acquisition-corp-ii-announces-the-separate-trading-of-its-6785084 Wed, 11 Nov 2026 11:00:00 GMT MALVERN, Pa., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM) (the "Company") today announced the pricing of its previously announced underwritten public offering of its common stock, comprised of 18,750,000 shares of common stock at a public offering price of $1.60 per share. The gross proceeds to the Company from this offering are expected to be approximately $30 million, before deducting underwriting discounts and commissions and other offering expenses payable by the Company. The Company also granted the underwriters a 30-day option to purchase up to an additional 2,812,500 shares of common stock at the public offering price per share, less underwriting discounts and https://www.quantisnow.com/insight/neuronetics-announces-pricing-of-30-million-underwritten-public-offering-of-6785065 https://www.quantisnow.com/insight/neuronetics-announces-pricing-of-30-million-underwritten-public-offering-of-6785065 Wed, 11 Nov 2026 03:39:49 GMT CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (NASDAQ:PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the pricing of an underwritten public offering of 35,714,286 shares of its common stock at a public offering price of $3.50 per share. Prime Medicine has also granted the underwriters a 30-day option to purchase up to an additional 5,357,142 shares of its common stock. The gross proceeds to Prime Medicine from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $125.0 million, excluding any exercise of https://www.quantisnow.com/insight/prime-medicine-announces-pricing-of-public-offering-of-common-stock-6785048 https://www.quantisnow.com/insight/prime-medicine-announces-pricing-of-public-offering-of-common-stock-6785048 Wed, 11 Nov 2026 02:40:47 GMT TRAVERSE CITY, Mich., Nov. 10, 2026 /PRNewswire/ -- Hagerty, Inc. (NYSE:HGTY) ("Hagerty"), a business that makes it easier and more enjoyable to be a driving enthusiast, announced the pricing of its secondary offering, upsized to 10,000,000 shares of Hagerty's Class A Common Stock, being offered by Hagerty Holding Corp. ("HHC" or the "Selling Stockholder") at a price to the public of $14.85 per share. In connection with the offering, the Selling Stockholder also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of Hagerty's Class A Common Stock. The offering is expected to close on or about November 12, 2026, subject to the satisfaction of customary cl https://www.quantisnow.com/insight/hagerty-announces-pricing-of-its-upsized-secondary-offering-of-class-6785013 https://www.quantisnow.com/insight/hagerty-announces-pricing-of-its-upsized-secondary-offering-of-class-6785013 Wed, 11 Nov 2026 01:53:00 GMT